Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic nalbuphine plus ondansetron for prevention of intrathecal morphine-induced pruritus after cesarean delivery
TCTR20260908002Phase 3Not yet recruiting
- Sponsor
- Patiphon Khummoo, M.D.
- Start
- Sep 2026
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nalbuphine, ondansetron in pruritus, sponsored by Patiphon Khummoo, M.D.. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
nalbuphineondansetron
03
Conditions
pruritus
Beyond the preview
Go deeper on TCTR20260908002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260908002.